SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.33-0.4%Nov 26 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (3506)4/21/2001 12:35:11 PM
From: JOEBT1  Read Replies (1) of 52153
 
Rick-< the route to superior returns in biotech>
Another route to superior returns in biotech:
1-Invest in "depressed" biotechs with an advanced clinical pipeline with high probability products on the market in 6 months to 3 years, eg, PRCS, SCIO, SEPR,HGSI,NBIX,IMGN, etc.
2-No limit on market cap provided that cash, technology value, discounted earnings project a much higher market cap, 2 to 3 times, over the next 2 to 4 years.

Ten baggers will not be as common as 1 to 4 years ago when many biotechs were significantly overvalued in the the mania market of the .Coms. However ,if anybody can do it, you can.
Your humble servant, :-) Joe
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext